ABT

7
Abbott Laboratories
Stock :NYSE
: Healthcare
: Medical Devices
Miracle Viewer
  30/09/2022 22:00 GMT+2
1.27
103.57684
96.97093
0.571

(2.1)
-0.023
-0.050
-0.07

Ruota il tuo smartphone per vedere un grafico migliore
Ruota il tuo smartphone per vedere un grafico migliore

Operativity type

LONG
Profit %
98.24 %
Timeframe
H 1
Duration
19
ABT
Sector: Health Technology
Industry: Medical Specialties
Employees: 109000


Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products.

It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products.

The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products.

The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites.

The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders.

The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.